602 related articles for article (PubMed ID: 15565327)
1. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
2. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Kaltwasser JP; Kessler U; Gottschalk R; Stucki G; Möller B
J Rheumatol; 2001 Nov; 28(11):2430-6. PubMed ID: 11708414
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
Hasegawa M; Kawamura N; Koide S; Murase M; Asano S; Toba T; Kushimoto H; Murakami K; Tomita M; Hasegawa H; Shikano M; Mizuno M; Funahashi N; Kawashima S; Sugiyama S
Nihon Jinzo Gakkai Shi; 2002; 44(5):453-63. PubMed ID: 12216478
[TBL] [Abstract][Full Text] [Related]
5. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
6. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
7. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Katodritou E; Terpos E; Zervas K; Speletas M; Kapetanos D; Kartsios C; Verrou E; Banti A; Effraimidou S; Christakis J
Ann Hematol; 2007 May; 86(5):369-76. PubMed ID: 17375302
[TBL] [Abstract][Full Text] [Related]
8. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
11. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
12. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
14. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
15. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
[TBL] [Abstract][Full Text] [Related]
16. [Effects of iron supplementation on human serum level of transferrin receptor].
Tian W; Lin XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):324-7. PubMed ID: 15498246
[TBL] [Abstract][Full Text] [Related]
17. The efficiency of fractionated parenteral iron treatment in CAPD patients.
Akcicek F; Ozkahya M; Cirit M; Ok E; Unsal A; Toz H; Celik A; Atabay G; Basci A
Adv Perit Dial; 1997; 13():109-12. PubMed ID: 9360661
[TBL] [Abstract][Full Text] [Related]
18. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
20. [Changes of serum transferrin receptor in children with iron deficiency and its response to iron supplementation].
Lin X; Long Z; Shen X
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):325-8. PubMed ID: 11769633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
